These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18939903)

  • 1. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke.
    Angeli F; Gentile G; Reboldi G; Verdecchia P
    Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1171-4. PubMed ID: 18939903
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of RAS modification for primary and secondary stroke prevention.
    Fintel DJ
    Postgrad Med; 2009 Jul; 121(4):115-22. PubMed ID: 19641277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should angiotensin II receptor blockers and statins be combined?
    Nickenig G
    Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin-converting enzyme inhibitors: clinical and experimental evidence.
    Chrysant SG
    J Hum Hypertens; 2005 Dec; 19(12):923-31. PubMed ID: 16049519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blockers: current status and future prospects.
    Kumar S; Ram CV
    Indian Heart J; 2007; 59(6):443-53. PubMed ID: 19151457
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV; Deedwania PC
    Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
    Dowlatshahi D; Hill MD
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):459-64. PubMed ID: 19419253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood pressure control in chronic stroke].
    Nagai M; Hoshide S; Kario K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():378-83. PubMed ID: 16981568
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
    Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S24-30. PubMed ID: 19450721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine for hypertension.
    Ménard J
    J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
    Baker WL; White CM
    Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005
    [No Abstract]   [Full Text] [Related]  

  • 14. Moving beyond angiotensin II to also target aldosterone?
    Little WC; Kirkman PM
    J Am Coll Cardiol; 2009 Aug; 54(6):513-4. PubMed ID: 19643311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic strategy for morning blood pressure elevation in elderly hypertensives].
    Sakima A; Takishita S
    Nihon Rinsho; 2005 Jun; 63(6):1086-90. PubMed ID: 15948395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005.
    Poulter N; Hughes AD; Williams B; Brady AJ; McInnes G;
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):104-21. PubMed ID: 17083065
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blockers: novel role in high-risk patients.
    Javed U; Deedwania PC
    Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor blockers and cerebral protection in stroke.
    Thöne-Reineke C; Steckelings UM; Unger T
    J Hypertens Suppl; 2006 Mar; 24(1):S115-21. PubMed ID: 16601564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Renin Report.
    Sica DA; Ichihara A
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):247-51. PubMed ID: 17347934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.